Nexalin Technology, Inc.
Public company- Headquarters
- HOUSTON, Texas
- Ticker
- NXL
- CIK
- 0001527352
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Senior Vice President of Quality, Regulatory, and Clinical AffairsCarolyn Shelton | Sep 2, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- Integer Holdings Corp
Plant closure: San Diego, CA
- ADM TRONICS UNLIMITED, INC.
director appointed: Michael Burychka
- Medtronic plc
President, Medtronic appointed: Michael Marinaro
- TransMedics Group, Inc.
CFO appointed: Fernando Araujo
- Executive departure
Senior Vice President of Quality, Regulatory, and Clinical Affairs departs: Carolyn Shelton
Carolyn Shelton, Senior Vice President of Quality, Regulatory, and Clinical Affairs of Nexalin Technology, Inc., departs the role, effective August 28, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 2, 2026Role: Senior Vice President of Quality, Regulatory, and Clinical Affairs
Only one public record so far. We add events as soon as a new filing lands; watch Nexalin Technology, Inc. to get them in your digest.
Last verified Nov 8, 2026